b12 Labs

b12 Labs offers an AI-powered copilot designed to assist chemists in the creation and testing of novel molecules. Functioning as a 'GPS' for chemistry, the platform aids pharmaceutical companies in strategically planning the synthesis of new drugs, significantly accelerating early-stage drug discovery processes from years to mere months. The company's technology is built upon groundbreaking research in autonomous AI agents capable of designing and synthesizing molecules in robotic laboratories, with publications in prestigious journals like Nature Machine Intelligence. b12 Labs is currently conducting paid pilot programs with major pharmaceutical corporations, demonstrating the platform's ability to optimize experimental planning and achieve rapid results, drastically reducing the iterative cycles typically required in drug development.